Efficacy and Safety of Neoantigen Peptide Vaccine in the Treatment of Advanced NSCLC Progressed After EGFR-TKI Treatment

Conditions

• NSCLC
• EGFR Gene Mutation

Interventions

• OTHER: neo-antigen vaccine

Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School